Skip to content

Prognostic Value of Lactates in ICU

Prognostic Value of Lactates in Predicting Intensive Care Unit Mortality

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04792736
Enrollment
135
Registered
2021-03-11
Start date
2019-06-01
Completion date
2020-07-31
Last updated
2021-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mortality

Keywords

Lactates, Prognosis, intensive care units

Brief summary

he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.

Detailed description

In this study, conducted over o 12 months period, arterial blood lactates levels were measured in ICU patients at admission (H0), every 6 hours during the first day and and H48. This trial included traumatic, medical and surgical patients requiring ICU stay for a predictive period \> to 24 hours. Blood lactates were evaluated as a prognostic parameter in predicting ICU mortality and compared to classic prognostic scores such as: SOFA score, IGS II and APACHE II. The primary end point was ICU mortality.

Interventions

DIAGNOSTIC_TESTBlood lactate level

Blood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48

Sponsors

Mongi Slim Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adults admissions in ICU with a predicted length of stay \> 24 hours

Exclusion criteria

* Patients who died during the first 24 hours after ICU admission

Design outcomes

Primary

MeasureTime frameDescription
ICU Mortality28 days after ICU admissionMortality at Day 28

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026